ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
문합 누출 장치 시장 규모는 2024년 34억 4,284만 달러에서 예측 기간 동안 5.59%의 연평균 복합 성장률(CAGR)로 성장하여 2032년에는 52억 9,462만 달러 규모로 성장할 것으로 예상됩니다.
문합 누출 장치 시장은 대장암 및 관상동맥질환(CAD) 증가, 규제기관의 승인 증가, 소화관 수술 건수 증가 등으로 인해 크게 성장하고 있습니다.
문합 누출 장치 시장 역학:
Global Cancer Observatory 2024의 자료에 따르면, 2022년 전 세계 대장암 환자 수는 약 192만 6,425명이었습니다. 이 데이터에 따르면 아시아가 96만 6,399명으로 전체의 거의 50%를 차지했고, 유럽이 53만 8,262명으로 뒤를 이었습니다. 전 세계적으로 대장암의 높은 발병률은 외과적 치료에 대한 수요를 주도하고 있으며, 문합 누출 장치는 장의 절제 및 재접합에 중요한 역할을 하고 있습니다. 이러한 장치는 수술의 정확성을 높이고 합병증을 줄이며 환자의 예후를 개선하기 때문에 대장암 수술에 필수적인 요소로 자리 잡으며 시장에서의 입지를 강화하고 있습니다.
British Heart Foundation, Global Heart &Circulatory Diseases Factsheet(2024)에 따르면, 현재 전 세계적으로 약 2억 명이 CAD 진단을 받고 있습니다. 문합 누출 장치는 관상동맥우회술(CABG)과 같은 수술의 정확성과 효율성을 높이고, 환자의 예후를 개선하며, 합병증을 감소시키기 때문에 CAD 치료에 점점 더 필수적인 요소가 되고 있습니다.
재사용 가능 부문은 2024년에 가장 큰 수익 점유율을 차지할 것으로 예상됩니다. 이는 주로 효율적인 혈관 연결을 위한 기술적으로 진보된 재사용 가능한 문합 누출 장치 개발에 대한 제조업체의 관심이 증가하고 있으며, 이 부문이 제공하는 다양한 이점이 있기 때문입니다.
재사용 가능한 문합 누출 장치는 심혈관 및 소화기 질환 환자에게 빠른 설치, 최소한의 조직 반응, 낮은 감염 위험, 강력한 상처 봉합을 제공합니다. 또한, 재사용 가능한 문합 누출 장치는 다양한 모양과 크기로 제공되어 수술 중 폐쇄 과정을 용이하게 합니다.
세계의 문합 누출 장치(Anastomosis Leakage Device) 시장을 조사했으며, 시장 개요, 시장 영향요인 및 시장 기회 분석, 시장 규제 환경, 시장 규모 추이와 예측, 각종 부문별/지역별/주요 국가별 상세 분석, 경쟁 구도, 주요 기업 개요 등의 정보를 정리하여 전해드립니다.
목차
제1장 문합 누출 장치 시장 보고서 : 서론
조사 범위
시장 세분화
시장 전제 요인
제2장 문합 누출 장치 시장 : 주요 요약
시장 개요
제3장 경쟁 구도
제4장 규제 분석
미국
유럽
일본
중국
제5장 문합 누출 장치 시장 : 주요 요인 분석
시장 성장 촉진요인
시장 성장 억제요인과 과제
시장 기회
제6장 문합 누출 장치 시장 : Porter의 Five Forces 분석
제7장 문합 누출 장치 시장 평가
사용성별
일회용
재이용 가능
용도별
심장혈관외과
소화기외과
기타
최종사용자별
병원
전문 클리닉
지역별
북미
유럽
아시아태평양
기타 지역
제8장 문합 누출 장치 시장 : 기업 및 제품 개요
Johnson & Johnson Services, Inc.
Medtronic
Baxter
BD
3M
Teleflex Incorporated
Integra LifeSciences
B.Braun Melsungen AG
Artivion
Stryker
Lydus Medical
GT Metabolic Solutions Inc.
Vascular Graft Solutions Ltd.
제9장 KOL(Key Opinion Leader)의 견해
제10장 프로젝트 접근
제11장 DelveInsight에 대해
제12장 면책사항 및 문의
LSH
영문 목차
영문목차
Anastomotic Leak Devices Market by Usability (Disposable and Reusable), Application (Cardiovascular Surgery, Gastrointestinal Surgery, and Others), End-User (Hospitals, Speciality Clinics, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to advance at a substantial CAGR forecast till 2032 owing to the increasing number of chronic disorders and the rising product developmental activities worldwide
The anastomotic leak devices market was valued at USD 3,442.84 million in 2024, growing at a CAGR of 5.59% during the forecast period from 2025 to 2032 to reach USD 5,294.62 million by 2032. The anastomotic leak devices market is growing significantly due to the increasing cases of colorectum cancers, and coronary artery disease (CAD) among the population, increasing clearances from regulatory bodies, growing number of gastrointestinal surgeries, among others that are expected to escalate the overall growth of the anastomotic leak devices market during the forecast period from 2025 to 2032.
Anastomotic Leak Devices Market Dynamics:
Data from the Global Cancer Observatory 2024, stated that in 2022, there were about 1,926,425 total cases of colorectum cancer worldwide. The same source further stated that Asia accounted for 966,399 colorectum cancer cases, comprising almost 50% of the total cases, and Europe accounted for 538,262 colorectum cancer cases. The high incidence of colorectal cancer globally drives the demand for surgical treatments, where anastomotic leak devices play a critical role in resecting and reconnecting the colon. These devices enhance surgical precision, reduce complications, and improve patient outcomes, making them indispensable in colorectal cancer surgeries and expanding their market presence.
According to British Heart Foundation, Global Heart & Circulatory Diseases Factsheet (2024), it stated that around 200 million people are currently living with CAD around the world. Anastomotic leak devices enhance precision and efficiency in procedures like coronary artery bypass grafting (CABG), improving patient outcomes and reducing complications, making them increasingly integral to CAD treatment.
Increased product development activities by regulatory bodies are also slated to witness market growth for anastomotic leak devices. For example, in January 2023, Lydus Medical announced that its Vesseal microvascular anastomosis suture deployment system received 510(k) clearance from the US Food and Drug Administration (FDA).
Hence, the interplay of all the above-mentioned factors is expected to drive the market for anastomotic leak devices market during the given forecast period from 2025 to 2032.
However, the risk of postoperative complications such as tissue irritation, infection, pressure necrosis, and others may limit their end-user base, thus acting as key constraints limiting the growth of the anastomotic leak devices.
Anastomotic Leak Devices Market Segment Analysis:
Anastomotic Leak Devices Market by Usability (Disposable and Reusable), Application (Cardiovascular Surgery, Gastrointestinal Surgery, and Others), End-User (Hospitals, Speciality Clinics, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)
In the usability segment of the anastomotic leak devices market, the reusable category is expected to have a significant revenue share in the year 2024. This is primarily owing to the rising focus of manufacturers towards developing technologically advanced reusable anastomotic leak devices for improved and efficient connection of vessels and the other various advantages offered by the category.
The reusable anastomotic leak devices provide quick placement, minimal tissue reaction, low risk of infection, and strong wound closure in patients with cardiovascular and gastrointestinal diseases. The reusable anastomotic leak devices are also available in different shapes and sizes, easing the process of closure during surgery.
Further, the increasing product launches and regulatory approvals for reusable anastomotic leak devices will aid in increasing their market demand. For instance, in March 2021, the FDA approved Viola clamps, a less proximal anastomotic leak device, and a new device for clamp proximal anastomosis in coronary artery bypass grafting (CABG).
Therefore, owing to the aforementioned factors, the reusable anastomotic leak devices category is expected to witness considerable growth eventually contributing to the overall growth of the global anastomotic leak devices market during the forecast period.
North America is expected to dominate the overall Anastomotic Leak Devices market:
Among all the regions, North America is estimated to hold a significant revenue share in the anastomotic leak devices market in 2024. This can be attributed to several factors such as the rising colorectum cancer cases, the presence of key market players, combined with significant advancements in product development and regulatory approvals, acting as key factors contributing to the growth of the anastomotic leak devices market in the North America region during the forecast period from 2025 to 2032.
According to data from the Global Cancer Observatory 2024, it stated that in the year 2022, there were 183,911 total colorectum cancer cases in the region. The same source further stated that the US accounted for 160,186 colorectum cancer cases which is almost 87% of the total cases, and Canada accounted for 23,725 colorectum cancer cases. Anastomotic leak devices are essential for reconnecting bowel segments during surgical resections. Advanced devices improve surgical precision, reduce complications, and enhance recovery, making them indispensable in managing colorectal cancer cases and expanding their market.
Additionally, in October 2024, GT Metabolic Solutions Inc., a global leader in magnetic compression anastomosis surgery, announced that the U.S. Food and Drug Administration cleared GT Metabolic's MagDI(TM) System for side-to-side duodeno-ileal (DI) anastomosis.
The prompt and well-established healthcare services and infrastructure further contribute to the growth of the regional anastomotic leak devices market growth. The presence of key players such as Johnson & Johnson Services, Inc., B.Braun Melsungen AG, and Medtronic with their strong distribution networks ensure widespread availability and accessibility of these devices across the region increasing their revenue shares in the market, and supportive reimbursement programs, providing immense growth opportunities for the same.
Therefore, the interplay of all the factors mentioned above would provide a conducive growth environment for the North America region in the anastomotic leak devices market during the forecast period from 2025 to 2032.
Anastomotic Leak Devices Market key players:
Some the key market players operating in the anastomotic leak devices market include Johnson & Johnson Services, Inc., Medtronic, Baxter, BD, 3M, Teleflex Incorporated, Integra LifeSciences, B.Braun Melsungen AG, Artivion, Stryker, Lydus Medical, GT Metabolic Solutions Inc., Vascular Graft Solutions Ltd., and others.
Recent Developmental Activities in the Anastomotic Leak Devices Market:
In April 2021, Ethicon announced the global launch of a new powered surgical stapler, with gripping surface technology.
In March 2021, Johnson & Johnson launched the ECHELON Stapler, a powered surgical stapler designed to reduce complications in surgery through more uniform tissue compression.
In February 2021, Vascular Graft Solutions Ltd. received marketing authorization from the FDA for VIOLA, a new device for clamp less proximal anastomosis in CABG.
Key takeaways from the Anastomotic Leak Devices market report study
Market size analysis for current Anastomotic Leak Devices market size (2024), and market forecast for 8 years (2025 to 2032)
Top key product/services developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
Key companies dominating the Anastomotic Leak Devices market
Various opportunities available for other competitors in the Anastomotic Leak Devices market space
What are the top-performing segments in 2024? How these segments will perform in 2032?
Which are the top-performing regions and countries in the current Anastomotic Leak Devices market scenario?
Which are the regions and countries where companies should have concentrated on opportunities for Anastomotic Leak Devices market growth in the coming future?
Target audience who can be benefited from this Anastomotic Leak Devices market report study
Anastomotic Leak Devices providers
Research organizations and consulting companies
Anastomotic Leak Devices-related organizations, associations, forums, and other alliances
Government and corporate offices
Start-up companies, venture capitalists, and private equity firms
Distributors and traders dealing in Anastomotic Leak Devices
Various end-users who want to know more about the Anastomotic Leak Devices market and the latest developments in the Anastomotic Leak Devices market
Frequently Asked Questions for the Anastomotic Leak Devices Market:
1. What are Anastomotic Leak Devices?
The anastomotic leak devices are medical tools or systems designed to prevent, detect, or treat leaks that occur at the site of a surgical anastomosis.
2. What is the market for Anastomotic Leak Devices?
The anastomotic leak devices market was valued at USD 3,442.84 million in 2024, growing at a CAGR of 5.59% during the forecast period from 2025 to 2032 to reach USD 5,294.62 million by 2032.
3. What are the drivers for the Anastomotic Leak Devices market?
The anastomotic leak devices market is growing significantly due to the increasing cases of colorectum cancers, coronary artery disease (CAD) among the population, clearances from regulatory bodies, and the growing number of gastrointestinal surgeries, among others that are expected to escalate the overall growth of the anastomotic leak devices market during the forecast period from 2025 to 2032.
4. Who are the key players operating in the Anastomotic Leak Devices market?
Some the key market players operating in the anastomotic leak devices market include Johnson & Johnson Services, Inc., Medtronic, Baxter, BD, 3M, Teleflex Incorporated, Integra LifeSciences, B.Braun Melsungen AG, Artivion, Stryker, Lydus Medical, GT Metabolic Solutions Inc., Vascular Graft Solutions Ltd., and others.
5. Which region has the highest share in the Anastomotic Leak Devices market?
Among all the regions, North America is estimated to hold a significant revenue share in the anastomotic leak devices market in 2024. This can be attributed to several factors such as the rising cases of colorectum cancers, the presence of key market players, combined with significant advancements in product developments and regulatory approvals that are acting as key factors contributing to the growth of the anastomotic leak devices market in the North America region during the forecast period from 2025 to 2032.
